Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users’ views

BackgroundWhole-exome sequencing (WES) consists in the capture, sequencing and analysis of all exons in the human genome. Originally developed in the research context, this technology is now increasingly used clinically to inform patient care. The implementation of WES into healthcare poses significant organizational, regulatory, and ethical hurdles, which are widely discussed in the literature.MethodsIn order to inform future policy decisions on the integration of WES into standard clinical practice, we performed a systematic literature review to identify the most important challenges directly reported by technology users.ResultsOut of 2094 articles, we selected and analyzed 147 which reported a total of 23 different challenges linked to the production, analysis, reporting and sharing of patients’ WES data. Interpretation of variants of unknown significance, incidental findings, and the cost and reimbursement of WES-based tests were the most reported challenges across all articles.ConclusionsWES is already used in the clinical setting, and may soon be considered the standard of care for specific medical conditions. Yet, technology users are calling for certain standards and guidelines to be published before this technology replaces more focused approaches such as gene panels sequencing. In addition, a number of infrastructural adjustments will have to be made for clinics to store, process and analyze the amounts of data produced by WES.

[1]  M. Sana,et al.  Novel &agr;-Actinin 2 Variant Associated With Familial Hypertrophic Cardiomyopathy and Juvenile Atrial Arrhythmias: A Massively Parallel Sequencing Study , 2014, Circulation. Cardiovascular genetics.

[2]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[3]  Jennifer B. McCormick,et al.  Genomic medicine and incidental findings: balancing actionability and patient autonomy. , 2014, Mayo Clinic proceedings.

[4]  Sandi Dheensa,et al.  Defining and managing incidental findings in genetic and genomic practice , 2014, Journal of Medical Genetics.

[5]  Kai Wang,et al.  Identifying disease mutations in genomic medicine settings: current challenges and how to accelerate progress , 2012, Genome Medicine.

[6]  W. Newman,et al.  Delivery of a Clinical Genomics Service , 2014, Genes.

[7]  Peter Tarczy-Hornoch,et al.  Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes. , 2014, Contemporary clinical trials.

[8]  Marilyn M. Li,et al.  Clinical application of amplicon-based next-generation sequencing in cancer. , 2013, Cancer genetics.

[9]  B. Fernandez,et al.  The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists , 2015, Journal of Medical Genetics.

[10]  Z. Xiong,et al.  Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system , 2014, Neurobiology of Aging.

[11]  L. Pizzi,et al.  Should patients with ocular genetic disorders have genetic testing? , 2014, Current opinion in ophthalmology.

[12]  Jacques S Beckmann,et al.  Can We Afford to Sequence Every Newborn Baby's Genome? , 2015, Human mutation.

[13]  Whole‐exome sequencing emerges as clinical diagnostic tool , 2014, American journal of medical genetics. Part A.

[14]  A. StAteMent.  ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing , 2014, Genetics in Medicine.

[15]  Arul M Chinnaiyan,et al.  Detection of somatic copy number alterations in cancer using targeted exome capture sequencing. , 2011, Neoplasia.

[16]  Megan Allyse,et al.  Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing. , 2013, Trends in biotechnology.

[17]  S. Cheung,et al.  Genetic diagnosis of autism spectrum disorders: The opportunity and challenge in the genomics era , 2014, Critical reviews in clinical laboratory sciences.

[18]  Clinical application of whole exome sequencing: not (yet) ready for primetime. , 2012, Current opinion in pediatrics.

[19]  Helvi Kyngäs,et al.  The qualitative content analysis process. , 2008, Journal of advanced nursing.

[20]  David B Jackson,et al.  Personalized cancer medicine—advances and socio-economic challenges , 2011, Nature Reviews Clinical Oncology.

[21]  J. Veltman,et al.  Clinical exome sequencing in daily practice: 1,000 patients and beyond , 2014, Genome Medicine.

[22]  P. Ellinor,et al.  Next-generation sequencing for the diagnosis of cardiac arrhythmia syndromes. , 2015, Heart rhythm.

[23]  Soma Das,et al.  Exome sequencing and the genetics of intellectual disability , 2011, Clinical genetics.

[24]  M. Mikati,et al.  Clinical utility of genetic testing in pediatric drug-resistant epilepsy: A pilot study , 2014, Epilepsy & Behavior.

[25]  David Tuck,et al.  Translating next generation sequencing to practice: Opportunities and necessary steps , 2013, Molecular oncology.

[26]  M. Simpson,et al.  Whole‐exome sequencing improves mutation detection in a diagnostic epidermolysis bullosa laboratory , 2015, The British journal of dermatology.

[27]  V. Sankaran,et al.  Applications of high-throughput DNA sequencing to benign hematology. , 2013, Blood.

[28]  Yingying Tang,et al.  Molecular diagnostics of cardiovascular diseases in sudden unexplained death. , 2014, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[29]  Nada Jabado,et al.  What can exome sequencing do for you? , 2011, Journal of Medical Genetics.

[30]  E. Vayena,et al.  Genetic incidental findings: autonomy regained? , 2013, Genetics in Medicine.

[31]  Gert Matthijs,et al.  Guidelines for diagnostic next-generation sequencing , 2015, European Journal of Human Genetics.

[32]  Janet K Williams,et al.  Challenges in evaluating next-generation sequence data for clinical decisions. , 2015, Nursing outlook.

[33]  Bartha Maria Knoppers,et al.  Return of genetic testing results in the era of whole-genome sequencing , 2015, Nature Reviews Genetics.

[34]  Xi Lin,et al.  Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities , 2012, Hearing Research.

[35]  A N Desai,et al.  Next‐generation sequencing: ready for the clinics? , 2012, Clinical genetics.

[36]  Emilie Devries-Seguin.  The Clinical Application of Genome-wide Sequencing for Monogenic Diseases in Canada: Position Statement of the Canadian College of Medical Geneticists , 2015 .

[37]  Hanns-Georg Klein,et al.  Whole genome sequencing (WGS), whole exome sequencing (WES) and clinical exome sequencing (CES) in patient care , 2014 .

[38]  J. Friedman,et al.  Paternalism and the ACMG recommendations on genomic incidental findings: patients seen but not heard , 2013, Genetics in Medicine.

[39]  J. Kleim,et al.  Linking Genes to Neurological Clinical Practice: The Genomic Basis for Neurorehabilitation , 2015, Journal of neurologic physical therapy : JNPT.

[40]  G. Piluso,et al.  Next generation sequencing (NGS) strategies for the genetic testing of myopathies , 2012, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[41]  K. J. Johansen Taber,et al.  The promise and challenges of next-generation genome sequencing for clinical care. , 2014, JAMA internal medicine.

[42]  Edwin Cuppen,et al.  Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects , 2015, European Journal of Human Genetics.

[43]  G. Hall,et al.  Genetic testing for inherited ocular disease: delivering on the promise at last? , 2014, Clinical & experimental ophthalmology.

[44]  R. Mayeux,et al.  Genetic variants in a ‘cAMP element binding protein’ (CREB)-dependent histone acetylation pathway influence memory performance in cognitively healthy elderly individuals , 2014, Neurobiology of Aging.

[45]  Jeremy M. Harris,et al.  Genomics in Clinical Practice: Lessons from the Front Lines , 2013, Science Translational Medicine.

[46]  T. Bird,et al.  Neurogenetics: Five new things. , 2011, Neurology. Clinical practice.

[47]  R. Pyeritz,et al.  Ethical Challenges of the Use of Whole Exome Sequencing in the Clinic , 2013, World journal for pediatric & congenital heart surgery.

[48]  J. Berg.  Genome-scale sequencing in clinical care: establishing molecular diagnoses and measuring value. , 2014, JAMA.

[49]  K. Boycott,et al.  Rare-disease genetics in the era of next-generation sequencing: discovery to translation , 2013, Nature Reviews Genetics.

[50]  Karl V Voelkerding,et al.  Developing genome and exome sequencing for candidate gene identification in inherited disorders: an integrated technical and bioinformatics approach. , 2013, Archives of pathology & laboratory medicine.

[51]  H. Burton,et al.  Personalised medicine in the UK: challenges of implementation and impact on healthcare system , 2014, Genome Medicine.

[52]  J. Graham,et al.  New genetic testing in prenatal diagnosis. , 2014, Seminars in fetal & neonatal medicine.

[53]  J. Berg,et al.  Next generation massively parallel sequencing of targeted exomes to identify genetic mutations in primary ciliary dyskinesia: Implications for application to clinical testing , 2011, Genetics in Medicine.

[54]  A. Kohlmann,et al.  Mutational profiling in patients with MDS: ready for every-day use in the clinic? , 2015, Best practice & research. Clinical haematology.

[55]  H. Jacob,et al.  A timely arrival for genomic medicine , 2011, Genetics in Medicine.

[56]  Hane Lee,et al.  Rethinking clinical practice: clinical implementation of exome sequencing. , 2012, Personalized medicine.

[57]  Ying Sheng,et al.  Identification of copy number variants from exome sequence data , 2014, BMC Genomics.

[58]  N. Knoers,et al.  Current insights into renal ciliopathies: what can genetics teach us? , 2012, Pediatric Nephrology.

[59]  M. Petticrew,et al.  Systematic Reviews in the Social Sciences: A Practical Guide , 2005 .

[60]  David J. Kerr,et al.  Clinical cancer research: the past, present and the future , 2014, Nature Reviews Clinical Oncology.

[61]  M. Hurles,et al.  Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound , 2014, Human molecular genetics.

[62]  R. Levine,et al.  Integrating genomics into prognostic models for AML. , 2014, Seminars in hematology.

[63]  Mustafa Tekin,et al.  The promise of whole-exome sequencing in medical genetics , 2013, Journal of Human Genetics.

[64]  M. Hammer,et al.  Nursing implications of personalized and precision medicine. , 2014, Seminars in oncology nursing.

[65]  F. André,et al.  Genomes in the clinic: the Gustave Roussy Cancer Center experience. , 2014, Current opinion in genetics & development.

[66]  Alka Malhotra,et al.  Whole exome sequencing for cancer – is there evidence of clinical utility? , 2014 .

[67]  L. Sastre.  Exome sequencing: what clinicians need to know , 2014 .

[68]  Raymond M. Moore,et al.  SoftSearch: Integration of Multiple Sequence Features to Identify Breakpoints of Structural Variations , 2013, PloS one.

[69]  Kelly Schoch,et al.  Clinical application of exome sequencing in undiagnosed genetic conditions , 2012, Journal of Medical Genetics.

[70]  K. Lohmann,et al.  Next Generation Sequencing and the Future of Genetic Diagnosis , 2014, Neurotherapeutics.

[71]  T. Graubert,et al.  AML genomics for the clinician. , 2014, Seminars in hematology (Print).

[72]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[73]  Jonathan A. Bernstein,et al.  Clinical whole-exome sequencing: are we there yet? , 2014, Genetics in Medicine.

[74]  R. Sinke,et al.  New clinical molecular diagnostic methods for congenital and inherited heart disease. , 2011, Expert opinion on medical diagnostics.

[75]  Jessie H. Conta,et al.  Practices and Policies of Clinical Exome Sequencing Providers: Analysis and Implications , 2013, American Journal of Medical Genetics. Part A.

[76]  C. Desmedt,et al.  Impact of tumor sequencing on the use of anticancer drugs , 2014, Current opinion in oncology.

[77]  S. Dacic,et al.  Present and Future Molecular Testing of Lung Carcinoma , 2014, Advances in Anatomic Pathology.

[78]  Olivia Freeman,et al.  Talking points personal outcomes approach: practical guide. , 2012 .

[79]  Madhuri Hegde,et al.  Implementing Genomic Medicine in Pathology , 2013, Advances in anatomic pathology.

[80]  G. Andria,et al.  Hyperhomocysteinemia: related genetic diseases and congenital defects, abnormal DNA methylation and newborn screening issues. , 2014, Molecular genetics and metabolism.

[81]  S. Sisodiya.  Genetic screening and diagnosis in epilepsy? , 2015, Current opinion in neurology.

[82]  B. Knoppers,et al.  Can I be sued for that? Liability risk and the disclosure of clinically significant genetic research findings , 2014, Genome research.

[83]  J. Polke,et al.  Clinical implications of genetic advances in Charcot–Marie–Tooth disease , 2013, Nature Reviews Neurology.

[84]  J. Schiffman,et al.  Translating genomic discoveries to the clinic in pediatric oncology , 2015, Current opinion in pediatrics.

[85]  J. Gécz,et al.  Developmental disorders: deciphering exomes on a grand scale , 2015, The Lancet.

[86]  D. Goldstein,et al.  Practical considerations in the clinical application of whole‐exome sequencing , 2016, Clinical genetics.

[87]  Jason O'Rawe,et al.  Human genetics and clinical aspects of neurodevelopmental disorders , 2014, bioRxiv.

[88]  Yuan Xue,et al.  Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing , 2014, Genetics in Medicine.

[89]  B Downe-Wamboldt,et al.  Content analysis: method, applications, and issues. , 1992, Health care for women international.

[90]  Eric D Wieben,et al.  Implementing individualized medicine into the medical practice , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[91]  A. StAteMent.  Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics , 2015, Genetics in Medicine.

[92]  Matthew S. Lebo,et al.  Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. , 2016, American journal of human genetics.

[93]  J. Rivière,et al.  Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic test , 2016, Clinical genetics.

[94]  A. Marian.  Sequencing your genome: what does it mean? , 2014, Methodist DeBakey cardiovascular journal.

[95]  S. Young,et al.  Molecular diagnostic testing of cytology specimens: current applications and future considerations. , 2014, Journal of the American Society of Cytopathology.

[96]  D. Liang,et al.  Copy number variation sequencing for comprehensive diagnosis of chromosome disease syndromes. , 2014, The Journal of molecular diagnostics : JMD.

[97]  Shivang Doshi,et al.  Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis , 2016, The Journal of molecular diagnostics : JMD.

[98]  Tadashi Kaname,et al.  A commentary on the promise of whole-exome sequencing in medical genetics , 2014, Journal of Human Genetics.

[99]  Gabrielle M. Christenhusz,et al.  Towards a European consensus for reporting incidental findings during clinical NGS testing , 2015, European Journal of Human Genetics.

[100]  S. Murphy,et al.  The spectrum of axonopathies , 2014, Neurology.

[101]  K. Knobloch,et al.  Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. , 2011, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.